Valsartan-hctz 160-25 MG tab 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FCX9F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,169
Award facts
- Contract value 100% obligated
- $10,169.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,169.31 to AmerSourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a non-set-aside competitive award. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerSourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
The contract supports DLA's critical mission to provide essential pharmaceutical products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerSourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its extensive portfolio of brand-name and generic medications. This particular task order for Valsartan-HCTZ, a common antihypertensive medication, demonstrates the company's role in supplying routine pharmaceutical commodities necessary for military personnel and veteran healthcare requirements. The non-set-aside competitive award structure reflects AmerSourceBergen's capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26FCX9F?
SPE2DR26FCX9F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCX9F worth?
The government has obligated $10,169 on SPE2DR26FCX9F.
Is contract SPE2DR26FCX9F an order under another contract?
Yes. SPE2DR26FCX9F is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX9F competed?
The extent of competition for SPE2DR26FCX9F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award